Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Pegfilgrastim-induced Bone Pain
NCT03407430Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jan 2016
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregabalin in bone pain, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Jan 2016; status: terminated.
02
Drugs
pregabalin
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT03407430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03407430.